Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-Cell Non-Hodgkin's Lymphoma
This study has been completed.
Sponsor:
Bayer
Information provided by:
Bayer
ClinicalTrials.gov Identifier:
NCT00220285
First received: September 21, 2005
Last updated: February 3, 2009
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2005 |
| Estimated Primary Completion Date: | No date given |
No publications provided by Bayer
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):